Similar Search Results

Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is therean Innovation System on the way?

Urias, Eduardo; Furtado, João - 2009

The Brazilian legislation did not recognize pharmaceutical patents for products and processes up until 1996, an exemption which started in 1945 for products and 1969, for processes. In this period, the domestic companies freely reproduced medicines developed by large companies from abroad and...

Persistent link: https://www.econbiz.de/10009476004

Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence

Urias, Eduardo; Ramani, Shyama V. - In: Journal of International Business Policy : JIBP 3 (2020) 4, pp. 367-384

Persistent link: https://www.econbiz.de/10012405471

High-value hi-tech product introduction in emerging countries : the role and construction of legitimacy

Ramani, Shyama V.; Thutupalli, Ajay; Urias, Eduardo - In: Qualitative market research : an international journal 20 (2017) 2, pp. 208-225

Persistent link: https://www.econbiz.de/10011714459

When access to drugs meets catch-up : insights from the use of CL threats to improve access to ARV drugs in Brazil

Ramani, Shyama V.; Urias, Eduardo - In: Research policy : policy, management and economic … 47 (2018) 8, pp. 1538-1552

Persistent link: https://www.econbiz.de/10011975860

High-value hi-tech product introduction in emerging countries

Ramani, Shyama V.; Thutupalli, Ajay; Urias, Eduardo - In: Qualitative Market Research: An International Journal 20 (2017) 2, pp. 208-225

Purpose This paper aims to study how multinational enterprises (MNEs) can best integrate legitimacy concerns into their new product-launching strategy to successfully introduce high-value hi-tech innovations in emerging countries. Design/methodology/approach Theoretical constructs on the role...

Persistent link: https://www.econbiz.de/10014987502